These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 20173208

  • 1. Primary prevention of sudden cardiac death after acute myocardial infarction: lessons from Leiden.
    McComb JM.
    Europace; 2010 Mar; 12(3):307-8. PubMed ID: 20173208
    [No Abstract] [Full Text] [Related]

  • 2. Timing of implantation of cardioverter-defibrillator after acute myocardial infarction.
    Huikuri HV.
    Europace; 2010 Aug; 12(8):1057-8. PubMed ID: 20501470
    [No Abstract] [Full Text] [Related]

  • 3. Implantation of cardioverter defibrillator in post-myocardial infarction patients: when and how?
    Efthimiadis GK, Mezilis NE, Styliadis IH.
    Eur Heart J; 2007 Oct; 28(19):2416. PubMed ID: 17656348
    [No Abstract] [Full Text] [Related]

  • 4. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A, Ghidina M.
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Structured care for patients after acute myocardial infarction: sudden cardiac death prevention--data from the Leiden MISSION! AMI study.
    Atary JZ, Borleffs CJ, Liem SS, Bax JJ, van der Hoeven BL, Bootsma M, van der Wall EE, van Erven L, Schalij MJ.
    Europace; 2010 Mar; 12(3):378-84. PubMed ID: 20056593
    [Abstract] [Full Text] [Related]

  • 7. [Sudden cardiac death after myocardial infarct. ICD and omega 3 fatty acids without preventive effect].
    Einecke D.
    MMW Fortschr Med; 2009 Apr 16; 151(16):14. PubMed ID: 19658288
    [No Abstract] [Full Text] [Related]

  • 8. Implantable cardioverter defibrillators after acute myocardial infarction.
    Liew R.
    BMJ; 2010 Nov 19; 341():c5741. PubMed ID: 21097570
    [No Abstract] [Full Text] [Related]

  • 9. Novel pathway for sudden cardiac death prevention.
    Herzog E, Aziz EF, Kukin M, Steinberg JS, Mittal S.
    Crit Pathw Cardiol; 2009 Mar 19; 8(1):1-6. PubMed ID: 19258831
    [Abstract] [Full Text] [Related]

  • 10. [Implantable cardioverter-defibrillators and mortality after myocardial infarct].
    Bonhorst D.
    Rev Port Cardiol; 1997 Apr 19; 16(4):355-7. PubMed ID: 9254125
    [No Abstract] [Full Text] [Related]

  • 11. Uncertainty on the use of aldosterone antagonists for primary therapy for sudden cardiac death in the setting of implanted devices.
    Kloner RA, Cannom DS.
    Circulation; 2007 Jun 12; 115(23):2983-9; discussion 2989. PubMed ID: 17562969
    [No Abstract] [Full Text] [Related]

  • 12. [Sudden cardiac death, ICD and resynchronization therapy].
    Schaumann A, Tack C, Kuck KH.
    Herz; 2006 Dec 12; 31(9):857-63. PubMed ID: 17180648
    [Abstract] [Full Text] [Related]

  • 13. [Primary prevention of sudden cardiac death].
    Reek S, Geller JC, Klein HU.
    Dtsch Med Wochenschr; 2001 Apr 12; 126(15):435-8. PubMed ID: 11347006
    [No Abstract] [Full Text] [Related]

  • 14. Cardioverter defibrillators. Should not be implanted in isolation after infarction.
    James M.
    BMJ; 2011 Jan 11; 342():d83. PubMed ID: 21224322
    [No Abstract] [Full Text] [Related]

  • 15. The Economics of ICDs.
    Jauhar S, Slotwiner DJ.
    N Engl J Med; 2004 Dec 09; 351(24):2542-4. PubMed ID: 15590958
    [No Abstract] [Full Text] [Related]

  • 16. [Primary prevention of sudden cardiac death].
    Burkhard-Meier C, Hoppe UC.
    Dtsch Med Wochenschr; 2003 Nov 28; 128(48):2547-52. PubMed ID: 14648439
    [No Abstract] [Full Text] [Related]

  • 17. [Sudden death: from epidemiology to therapeutic management-prevention].
    Aliot E.
    Arch Mal Coeur Vaiss; 2000 Jun 28; Spec No():27-9. PubMed ID: 10949712
    [No Abstract] [Full Text] [Related]

  • 18. Risk of sudden death after discharge following myocardial infarction.
    Birnie DH, Cobbe SM.
    Eur Heart J; 2001 Jul 28; 22(14):1153-5. PubMed ID: 11440487
    [No Abstract] [Full Text] [Related]

  • 19. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C.
    Arch Intern Med; 2009 Sep 14; 169(16):1500-6. PubMed ID: 19752408
    [Abstract] [Full Text] [Related]

  • 20. Primary prevention: a necessity after myocardial infarction with left ventricular dysfunction.
    Valk S, Jordaens L.
    Europace; 2009 Apr 14; 11(4):407-8. PubMed ID: 19279027
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.